Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution Study
Authors:
- Andrea MaurichiAMAndrea Maurichi
- Rosalba MiceliRMRosalba Miceli
- Tiziana CameriniTCTiziana Camerini
- Luigi MarianiLMLuigi Mariani
- Roberto PatuzzoRPRoberto Patuzzo
- Roberta RuggeriRRRoberta Ruggeri
- Gianfranco GallinoGGGianfranco Gallino
- Elena TolomioETElena Tolomio
- Gabrina TragniGTGabrina Tragni
- Barbara ValeriBVBarbara Valeri
- Andrea AnichiniAAAndrea Anichini
- Roberta MortariniRMRoberta Mortarini
- 10 August 2014
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (23) , 2479-2485
Abstract
Purpose: Cutaneous melanoma incidence is increasing. Most new cases are thin (≤ 1 mm) with favorable prognoses, but survival is nonetheless variable. Our aim was to investigate new prognostic factors and construct a nomogram for predicting survival in individual patients. Patients and Methods: Data from 2,243 patients with thin melanoma were retrieved from prospectively maintained databases at six centers. Kaplan-Meier survival and crude cumulative incidences of recurrence were estimated, and competing risks were taken into account. Multivariable Cox regression was used to investigate survival predictors. Results: Median follow-up was 124 months (interquartile range, 106 to 157 months); 12-year overall survival was 85.3% (95% CI, 83.4% to 87.2%). Median times to local, regional, and distant recurrence were 79, 78, and 107 months, respectively. Relapse was significantly related to age, Breslow thickness, mitotic rate (MR), ulceration, lymphovascular invasion (LVI), and regression; incidence was lower and subgroup differences were less marked for distant metastasis than for regional relapse. The worst prognosis categories were age older than 60 years, Breslow thickness more than 0.75 mm, MR ≥ 1, presence of ulceration, presence of LVI, and regression ≥ 50%. Breslow thickness more than 0.75 mm, MR ≥ 1, presence of ulceration, and LVI (all P = .001) were significantly associated with sentinel node positivity. Age, MR, ulceration, LVI, regression, and sentinel node status were independent predictors of survival and were used to construct a nomogram to predict 12-year overall survival. The nomogram was well calibrated and had good discriminative ability (adjusted Harrell C statistic, 0.88). Conclusion: Our findings suggest including LVI and regression as new prognostic factors in the melanoma staging system. The nomogram appears useful for risk stratification in clinical management and for recruiting patients to clinical trials.Keywords
This publication has 28 references indexed in Scilit:
- Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanomaMelanoma Research, 2012
- Lymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous MelanomaClinical Cancer Research, 2012
- Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous MelanomaAnnals of Surgery, 2012
- Fifty years of cancer incidence: CI5 I–IXInternational Journal of Cancer, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Results of Sentinel Lymph Node Biopsy in Patients With Thin MelanomaAnnals of Surgical Oncology, 2006
- Thin MelanomasAnnals of Surgery, 2003
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Partial residuals for the proportional hazards regression modelBiometrika, 1982